Equity Profile

LMAT

LeMaitre Vascular, Inc.

Health CareHealth Care Equipment$2.1B

May5Tue

Post-Earnings Recap

ReportedQ1-2026After Close4:05 PM EDT

LeMaitre Vascular Beats on EPS, Stock Up 0.42%

Metric	Actual	Expected	Surprise
EPS	$0.68	$0.66	+2.56%
Revenue	—	$67M	—

management commentary, guidance changes, and full analysis available with Pro.

LeMaitre Vascular Beats on EPS, Stock Up 0.42%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$0.68	$0.66	+2.56%
Revenue	—	$67M	—

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

What It Means

LeMaitre Vascular reported better-than-expected earnings per share, which contributed to a slight increase in the stock price by 0.42%. However, the company did not provide revenue figures or any forward guidance, leaving investors without additional context for future performance. The positive EPS surprise may indicate operational strength, but the lack of revenue data could raise questions about overall growth.

Company Snapshot

LeMaitre Vascular, Inc. (LMAT) is a healthcare company that specializes in developing and selling medical devices for vascular surgery....

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of profitability and will show how well the company is managing its costs and generating profits.

$0.66

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its products.

$67M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

LeMaitre Vascular, Inc. (LMAT) is a healthcare company that specializes in developing and selling medical devices for vascular surgery. With a market cap of $3 billion, it plays a crucial role in the healthcare equipment sector, particularly as demand for innovative surgical solutions continues to grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+4.17%

Avg Stock Reaction

-0.41%

Last Quarter Recap

In Q4-2025, LeMaitre reported an EPS of $0.68, slightly beating expectations of $0.67. The stock reacted positively, gaining 0.69% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect LeMaitre to report solid earnings this quarter, with a consensus EPS of $0.66 and revenue of $67 million. The company has a history of beating earnings estimates, which could lead to positive market reactions.

Bull Case

If LeMaitre exceeds the EPS estimate and shows strong revenue growth, it could signal robust demand for its products, leading to a significant stock price increase.

Bear Case

Conversely, if the company misses its earnings or revenue targets, it may raise concerns about its growth prospects, resulting in a negative reaction from investors.

Key Metrics to Watch

EPS

$0.66

Earnings per share (EPS) is a key indicator of profitability and will show how well the company is managing its costs and generating profits.

Revenue

$67M

Revenue figures provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $0.66?

A beat on EPS could reinforce investor confidence in the company's profitability and growth trajectory.

What are the revenue expectations for this quarter compared to the consensus of $67 million?

Revenue growth is critical for assessing market demand and the company's ability to expand its product offerings.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for revenue growth driven by new product launches and expanding market share.

Supporting Evidence

LeMaitre has consistently beaten EPS estimates, suggesting a trend of stronger-than-expected performance.

The options market is pricing a larger move than historical averages, indicating heightened expectations.

Recent trends in healthcare spending may support increased demand for LeMaitre's products.

Key Risk

If revenue growth exceeds $68 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be pivotal in determining whether LeMaitre can sustain its growth momentum or if it faces challenges in the current market.

Bull Confirmed If

An EPS of $0.70 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $0.64 would raise concerns about the company's growth and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±10.43%

Historical Avg

±1.1%

Pricing rich

The options market is pricing in a significant move of about 10.43%, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±9.9% while LMAT has averaged ±1.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

29.2%

Calls (0)P/C Ratio: 2.33Puts (200)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LeMaitre beats expectations, history suggests a positive stock reaction, averaging a 1-day move of +0.81%.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in future growth.

Miss

A miss could lead to a negative reaction, with history indicating an average 1-day move of -1.80% when expectations are not met.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into market demand trends for vascular surgery products.
3Management's commentary on cost management and profitability strategies.
4Details on geographic expansion and market penetration efforts.
5Any changes in guidance or outlook for the remainder of the fiscal year.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

LeMaitre Vascular, Inc. (LMAT) is a healthcare company that specializes in developing and selling medical devices for vascular surgery....

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of profitability and will show how well the company is managing its costs and generating profits.

$0.66

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its products.

$67M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+4.17%

Avg Stock Reaction

-0.41%

Last Quarter Recap

In Q4-2025, LeMaitre reported an EPS of $0.68, slightly beating expectations of $0.67. The stock reacted positively, gaining 0.69% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If LeMaitre exceeds the EPS estimate and shows strong revenue growth, it could signal robust demand for its products, leading to a significant stock price increase.

Bear Case

Conversely, if the company misses its earnings or revenue targets, it may raise concerns about its growth prospects, resulting in a negative reaction from investors.

Key Metrics to Watch

EPS

$0.66

Earnings per share (EPS) is a key indicator of profitability and will show how well the company is managing its costs and generating profits.

Revenue

$67M

Revenue figures provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $0.66?

A beat on EPS could reinforce investor confidence in the company's profitability and growth trajectory.

What are the revenue expectations for this quarter compared to the consensus of $67 million?

Revenue growth is critical for assessing market demand and the company's ability to expand its product offerings.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for revenue growth driven by new product launches and expanding market share.

Supporting Evidence

LeMaitre has consistently beaten EPS estimates, suggesting a trend of stronger-than-expected performance.

The options market is pricing a larger move than historical averages, indicating heightened expectations.

Recent trends in healthcare spending may support increased demand for LeMaitre's products.

Key Risk

If revenue growth exceeds $68 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be pivotal in determining whether LeMaitre can sustain its growth momentum or if it faces challenges in the current market.

Bull Confirmed If

An EPS of $0.70 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $0.64 would raise concerns about the company's growth and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±10.43%

Historical Avg

±1.1%

Pricing rich

The options market is pricing in a significant move of about 10.43%, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±9.9% while LMAT has averaged ±1.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

29.2%

Calls (0)P/C Ratio: 2.33Puts (200)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LeMaitre beats expectations, history suggests a positive stock reaction, averaging a 1-day move of +0.81%.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in future growth.

Miss

A miss could lead to a negative reaction, with history indicating an average 1-day move of -1.80% when expectations are not met.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into market demand trends for vascular surgery products.
3Management's commentary on cost management and profitability strategies.
4Details on geographic expansion and market penetration efforts.
5Any changes in guidance or outlook for the remainder of the fiscal year.